Veterinary Medicines

CEVAC Megamune ND-IB-EDS-SHS K vakcina A.U.V.

Authorised
  • Newcastle disease virus, strain La Sota, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Eggdrop syndrome-1976 virus, strain B8/78, Inactivated
  • Avian infectious bronchitis virus, strain QX FR, Inactivated
  • Turkey rhinotracheitis virus, strain TRT50, Inactivated
Download as PDF

Product identification

Medicine name:
CEVAC Megamune ND-IB-EDS-SHS K vakcina A.U.V.
Active substance:
  • Newcastle disease virus, strain La Sota, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Eggdrop syndrome-1976 virus, strain B8/78, Inactivated
  • Avian infectious bronchitis virus, strain QX FR, Inactivated
  • Turkey rhinotracheitis virus, strain TRT50, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Newcastle disease virus, strain La Sota, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    4.90
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
  • Eggdrop syndrome-1976 virus, strain B8/78, Inactivated
    7.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
  • Avian infectious bronchitis virus, strain QX FR, Inactivated
    1.00
    relative potency
    /
    1.00
    unit(s)/dose
  • Turkey rhinotracheitis virus, strain TRT50, Inactivated
    20.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA18
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva-Phylaxia Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: